Your browser doesn't support javascript.
loading
Felbamate urolithiasis.
Bergelson, Ilana; Walker, Chance; Frank, Elizabeth L; Steinberg, Ryan.
Afiliación
  • Bergelson I; Department of Urology, The University of Iowa Hospitals and Clinics, Iowa City, lowa, USA ilana-bergelson@uiowa.edu.
  • Walker C; Department of Pathology, University of Utah Health, Salt Lake City, Utah, USA.
  • Frank EL; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA.
  • Steinberg R; ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, USA.
BMJ Case Rep ; 16(12)2023 Dec 21.
Article en En | MEDLINE | ID: mdl-38129082
ABSTRACT
Drug-induced nephrolithiasis is an important consideration in recurrent stone formers with polypharmacy. While felbamate nephrolithiasis has previously been published in the paediatric population, we present the oldest published case of a felbamate stone in an adult, a man in his 30s with Lennox-Gastaut syndrome. Even with moderate dosing, high drug serum levels can occur. Performing at least one stone analysis remains a critical component to care in these patients. Urologists should have a high index of suspicion for drug stone when stone analysis returns indeterminate characterisation in the absence of infection. Close communication with neurology is key to preventing recurrent stone disease.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Epilepsia / Nefrolitiasis / Urolitiasis / Felbamato Límite: Adult / Humans / Male Idioma: En Revista: BMJ Case Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Epilepsia / Nefrolitiasis / Urolitiasis / Felbamato Límite: Adult / Humans / Male Idioma: En Revista: BMJ Case Rep Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido